Tilt Biotherapeutics
Series BTilt Biotherapeutics raised €22M in a Series B round in May 2025. The company is based in Helsinki, Finland. Investors in the round: European Innovation Council (EIC), Finnish Industry Investment (Tesi), Lifeline Ventures and 1 other. Data as of 4 Nov 2026.
Amount raised
€22M
€22,498,200
Native amount
25,000,000 USD
Stage
Series B
series b
Investors
4
Provenance & confidence
High confidenceAmount
25,000,000 USD
ECB-at-date → €22M · rate 1.1112 on 2025-05-13
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
4 namedEuropean Innovation Council (EIC)Finnish Industry Investment (Tesi)Lifeline VenturesStephen Industries
Date
May 2025
Round type
series b
Amount (EUR)
€22M